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In June 2006, the United States Centers for Disease Control
first recommended the administration of the human papilloma-
virus (HPV) vaccine to 11–12-year-old girls. The HPV Vaccine
Controversy is a testimony of the amazing uprise of interest and
discussion that accompanied this recommendation and the arrival
of the first HPV vaccine, and follows it through 2008, up to the
time when the book was published. The author, Dr Shobha
Krishnan, explains that the book’s target audience is parents,
women, men and teenagers.
Overall, Dr Krishnan provides a well-balanced view of the
strengths and weaknesses of the currently available prophylactic
HPV vaccines, including the need to continue screening efforts,
and to avoid feelings of fear and guilt on the part of a woman
when a HPV infection is detected during cervical cancer screening.
The book, however, is very long and is full of technicalities. It
made me wonder if, in order to make up their mind, the lay public
was anxious to know so many details on HPV types that are not
included in the current vaccines, or on the cervical cancer staging
system. It is true that when ‘ysex, science, and morals of society
intersect.’ (author’s note, page xiii), everybody has something to
say, but other lines of reflection could have been, in my view, more
fecund for the lay public.
How was it, for instance, that after 13 years of deliberation,
both Merck and Glaxo Smith Kline signed royalty agreements
with four, mainly tax-payer-supported, institutes (pages 97–98) so
that their original research could be applied to developing and
manufacturing ‘a vaccine that was released at the highest price in
history’? Why is there so much insistence on sexually transmitted
diseases when the HPV vaccine has been conceived, and should
have been promoted, as the vaccine against cervical cancer?
An obvious side effect of the length of the book is the increase in
the scope for inaccuracies and already out-of-date scientific
statements. For instance, some myths are presented as facts, for
example, ‘The teenage cervix is most vulnerable to HPVy’ (page
23), or ‘Men should be equal players in reducing the viral load in
society’ (page 134). The first statement is often heard, but it has no
clear scientific support. The second is the result of a misunder-
standing (although it is a general wish that a cheap vaccine may be
ultimately given to all infants, regardless of sex). In reality, good
vaccine coverage of one sex is enough to curb HPV infection for
the same reason Dr Krishnan believes the contrary, that is, because
transmission is mainly from one sex to another. Women, however,
have a stronger need to be vaccinated than men as it is they who
develop the most severe and frequent disease associated with HPV,
that is, cervical cancer.
Appropriately, the book ends not in the United States, but in
India, with a touching expression of gratitude from a 37-year-old
woman whose life was saved in the 1990s by the early detection of
cervical cancer (pages 187–188). Almost certainly, her daughters
have already missed the chance to benefit from the vaccine against
cervical cancer. Will her granddaughters miss it too?
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